Last time I checked, the FDA is supposed to working for us, the taxpayers. And the culmination of the attacks on the FDA by investors was not the letter to CytoDyn but the outing of the FDA approved Aduhelm (aducanumab) for the treatment of Alzheimer's. But you know the BP - FDA revolving door scam on the drug industry, how else could a drug be $787 at one place for you insurance and $28 at another retail.

So we weren't supposed to complain about the 400,000 people who died after the EUA and later approval of Remdesivir and an EUA for hydroxychloroquine. What's not to complain about. Leronlimab works for some people with Covid19, not all, but some, we knew that in April 2020 and the FDA did everything in its power to bury that fact.